Benefit evaluation in the therapy of chronic wounds from the patients' perspective-development and validation of a new method

Wound Repair and Regeneration

Volumn 20, Issue 1, 2012, Pages 8-14

  Augustin, Matthias ^a   Blome, Christine ^a   Zschocke, Ina ^b   Schäfer, Ines ^a   Koenig, Sibylle ^a   Rustenbach, Stephan J ^a   Herberger, Katharina ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b SCIderm GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC WOUND; CONSTRUCT VALIDITY; CRONBACH ALPHA COEFFICIENT; FEASIBILITY STUDY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PATIENT SATISFACTION; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; TREATMENT OUTCOME; VACUUM ASSISTED CLOSURE; VALIDATION STUDY;

CHRONIC DISEASE; FEASIBILITY STUDIES; FEMALE; GERMANY; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; WOUNDS AND INJURIES;

EID: 84856352584     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2011.00751.x     Document Type: Article

References (43)

1. Briggs M, Ferris FD, Glynn C, Harding K, Hofman D, Hollinworth H, Krasner DL, Lindholm C, Moffatt C, Price P, Romanelli M, Sibbald G, Stacey M, Téot L, World Union of Wound healing Societies Expert Working Group. Assessing pain at wound dressing-related procedures. Nurs Times 2004; 100: 56-57.
2. Augustin M, Dieterle W, Zschocke I, Brill C, Trefzer D, Peschen M, Schöpf E, Vanscheidt W,. Development and validation of a disease specific questionnaire on the quality of life of patients with chronic venous insufficiency. Vasa 1997; 26: 291-301. (Pubitemid 27501942)
3. Price P, Harding K,. Cardiff Wound Impact Schedule: the development of a condition-specific questionnaire to assess health-related quality of life in patients with chronic wounds of the lower limb. Int Wound J 2004; 1: 10-17.
4. Lindholm C, Bjellerup M, Christensen OB, Zederfeldt B,. Quality of life in chronic leg ulcer patients. An assessment according to the Nottingham Health Profile. Acta Derm Venereol 1993; 73: 440-443. (Pubitemid 23351344)
5. Phillips T, Stanton B, Provan A, Lew R,. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol 1994; 31: 49-53. (Pubitemid 24198162)
6. Zschocke I, Bross F, Maier K, Vanscheidt W, Augustin M,. Quality of life in different stages of chronic venous insufficiency and leg ulcer. Dermatol Psychosom 2002; 3: 126-131. (Pubitemid 35316806)
7. Franks PJ, Moffatt PJ, Connolly M, Bosanquet N, Oldroyd M, Greenhalgh R, McCollum C,. Community leg ulcer clinics: effect on quality of life. Phlebologie 1994; 9: 83-86. (Pubitemid 24209806)
8. Augustin M, Ermuth T, Johnson S, Schöpf E, Vanscheidt W, Zschocke I,. Effects of autologous keratinocyte transplantation on the quality of life of patients with severe chronic leg ulcers. Dermatol Psychosom 2001; 2: 73-76. (Pubitemid 32642039)
9. Rychlik R, Rusche H, Augustin M,. Systematik der Nutzenbewertung von Arzneimitteln. Gesundh Ökon Qual Manag 2004; 9: 245-252. (Pubitemid 39302481)
10. Zentner A, Velasco-Garrido M, Busse R,. Methods for the comparative evaluation of pharmaceuticals. GMS Health Technol Assess 2005; 1:Doc09; [electronic version:; accessed November 16, 2011].
11. Zschocke I, Hammelmann U, Augustin M,. Therapeutischer Nutzen in der dermatologischen Behandlung. [Therapeutic benefits in dermatological therapy.]. Hautarzt 2005; 56: 839-846. (Pubitemid 41224048)
12. Fünftes buch sozialgesetzbuch. 35b Abs. 1. [German social security statute book.]
13. Bastian H, Bender R, Ernst AS, Kaiser T, Kirchner H, Kolominsky-Rabas P, Lange S, Sawicky PT, Weber M,. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Methoden. Version 2.0 vom 19.12.2006. Köln: 2007.
14. Gemeinsamer Bundesausschuss. Verfahrensordnung vom 20.09.2005. Bundesanzeiger 2005; 242: 16998.
15. Bundesministerium für Gesundheit. Gesetz zur Stärkung des Wettbewerbs in der gesetzlichen Krankenversicherung vom 26.03.2007. Bundesanzeiger 2007; 66: 3613.
16. Clark MS, Caudrey DJ,. Evaluation of rehabilitation services: the use of goal attainment scaling. Int Rehabil Med 1982; 5: 41-45.
17. Ottenbacher KJ, Cusick A,. Goal attainment scaling as a method of clinical service evaluation. Am J Occup Ther 1990; 44: 519-525.
18. Donnelly C, Carswell A,. Individualized outcome measures: a review of the literature. Can J Occup Ther 2002; 69: 84-94. (Pubitemid 34415133)
19. Fisher K, Hardie RJ,. Goal attainment scaling in evaluating a multidisciplinary pain management programme. Clin Rehabil 2002; 16: 871-877. (Pubitemid 35469342)
20. Rushton PW, Miller WC,. Goal attainment scaling in the rehabilitation of patients with lower-extremity amputations: a pilot study. Arch Phys Med Rehabil 2002; 83: 771-775. (Pubitemid 34721475)
21. Rockwood K, Howlett S, Stadnyk K, Carver D, Powell C, Stolee P,. Responsiveness of goal attainment scaling in randomized controlled trial of comprehensive geriatric assessment. J Clin Epidemiol 2003; 56: 736-743. (Pubitemid 37040809)
22. Steinbook RM, Jacobson AF, Mosher JC, Davies DL,. The goal attainment scale: an instructional guide for the delivery of social reinforcement. Arch Gen Psychiatry 1977; 34: 923-926. (Pubitemid 8163833)
23. Gordon JE, Powell C, Rockwood K,. Goal attainment scaling as a measure of clinically important change in nursing-home patients. Age Ageing 1999; 28: 275-281. (Pubitemid 29229331)
24. Turnbull J,. Evaluating health care using goal attainment scaling. Nurs Stand 1998; 12: 35-38.
25. Boothroyd RA, Banks SM, Evans ME, Greenbaum PE, Brown E,. Untangling the web: an approach to analyzing the impacts of individually tailored, multicomponent treatment interventions. Ment Health Serv Res 2004; 6: 143-153. (Pubitemid 39140114)
26. Steffanowski A, Lichtenberg S, Schmidt J, Huber C, Wittmann WW, Nübling R,. Ergebnisqualität psychosomatischer Rehabilitation: Zielerreichungsskalierung auf der Basis einer strukturierten Therapiezielliste. Rehabilitation 2004; 43: 219-232. (Pubitemid 39221289)
27. Zwingmann C,. Zielorientierte Ergebnismessung (ZOE) mit dem IRES-Patientenfragebogen Eine kritische Zwischenbilanz. Rehabilitation 2003; 42: 226-235. (Pubitemid 37099293)
28. Augustin M, Radtke MA, Zschocke I, Blome C, Behechtnejad J, Schäfer I, Reusch M, Mielke V, Rustenbach SJ,. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 2009; 301: 561-571.
29. Blome C, Augustin M, Siepmann D, Phan NQ, Rustenbach SJ, Ständer S,. Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Br J Dermatol 2009; 161: 1143-1148.
30. Bowling A,. Measuring disease: a review of disease-specific quality of life measurement scales. Buckingham: Open University Press, 1995.
31. Guyatt GH, Walter S, Norman G,. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 1987; 40: 171-178. (Pubitemid 17007065)
32. Lienert G,. Testaufbau und testanalyse, 6. Auflage. Weinheim: Beltz, 1998.
33. Smith GT, editor. Measuring health: a practical approach. Chichester, New York, Brisbane, Toronto, Singapore: John Wiley, 1988.
34. Koller M, Neugebauer EAM, Augustin M, Büssing A, Farin E, Klinkhammer-Schalke M, Lorenz W, Münch K, Petersen-Ewert C, Steinbüchel N, Wieseler B,. Die Erfassung von Lebensqualität in der Versorgungsforschung-konzeptuelle, methodische und strukturelle Voraussetzungen. Gesundheitswesen 2009; 71: 864-872.
35. Augustin M, Amon U, Braathen L, Bullinger M, Gieler U, Klein GF, Schultz-Amling W,. Erfassung von Lebensqualität in der Dermatologie (Leitlinie). [Guideline on the assessment of quality of life in dermatology.]. J Dtsch Dermatol Ges 2004; 9: 802-806.
36. Augustin M, Zschocke I, Lange S, Seidenglanz K, Amon U,. Quality of life in skin diseases: methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis. Hautarzt 1999; 50: 715-722. (Pubitemid 29502766)
37. Augustin M, Zschocke I,. Nutzenbewertung der ambulanten und stationären VAC-Therapie aus Patientensicht: Multicenterstudie mit patientenrelevanten Endpunkten. MMW Fortschr Med 2006; 148: 25-32.
38. Victor N, Windeler J, Hasford J, Köpcke W, Linden M, Michaelis J, Röhmel J, Schäfer H,. Empfehlungen zur Durchführung von Anwendungsbeobachtungen [Recommendations concerning the conduct of "Anwendungsbeobachtungen"]. Inform Biom Epidemiol Med Biol 1997; 28: 247-252.
39. The EuroQol group. EuroQol-a new facility for the measurement of health related quality of life. Health Policy 1990; 16: 199-208.
40. Brazier J, Dixon S,. The use of condition specific outcome measures in economic appraisal. Health Econ 1995; 4: 255-264.
41. Brock D,. Quality of life measures in health care and medical ethics. In:, Spilker B, editor. Quality of Life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven, 1996: 487-510.
42. Drummond M, McGuire A,. Economic evaluation in health care. Oxford: Oxford University Press, 2001.
43. Feeny DH, Torrance GW, Labelle R,. Integrating economics evaluations and quality of life assessments. In:, Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven, 1996: 85-95.